메뉴 건너뛰기
Journal of Clinical Oncology
Volumn 25, Issue 22, 2007, Pages 3191-3193
Sound footing or slippery slope? The value of secondary analyses of randomized trials
Author keywords

[No Author keywords available]
Indexed keywords

BEVACIZUMAB; CAPECITABINE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN; UFT;
EID: 34548268151     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2007.11.5089     Document Type: Editorial
Times cited : (2)
References (8)
  • 1
    • 0033874892 scopus 로고    scopus 로고
    • Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer
    • de Gramont A, Figer A, Seymour M, et al: Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 18:2938-2947, 2000
    • (2000) J Clin Oncol , vol.18 , pp. 2938-2947
    • de Gramont, A.1    Figer, A.2    Seymour, M.3
  • 2
    • 6444229308 scopus 로고    scopus 로고
    • N9741: FOLFOX (oxaliplatin (Oxal)/5-fluorouracil (5-FU)/leucovorin (LV)) or reduced dose R-IFL (CPT-11 + 5-FU/LV) in advanced colorectal cancer (CRC): Final efficacy data from an intergroup study
    • suppl, abstr 3621
    • Goldberg RM, Sargent D, Morton RF, et al: N9741: FOLFOX (oxaliplatin (Oxal)/5-fluorouracil (5-FU)/leucovorin (LV)) or reduced dose R-IFL (CPT-11 + 5-FU/LV) in advanced colorectal cancer (CRC): Final efficacy data from an intergroup study. J Clin Oncol 22:275, 2004 (suppl, abstr 3621)
    • (2004) J Clin Oncol , vol.22 , pp. 275
    • Goldberg, R.M.1    Sargent, D.2    Morton, R.F.3
  • 3
    • 34248225777 scopus 로고    scopus 로고
    • Detailed analysis of oxaliplatin-associated neurotoxicity in Intergroup trial N9741
    • suppl 3, abstr 2540
    • Green E, Sargent D, Goldberg RM, et al: Detailed analysis of oxaliplatin-associated neurotoxicity in Intergroup trial N9741. Ann Oncol 15:70, 2004 (suppl 3, abstr 2540)
    • (2004) Ann Oncol , vol.15 , pp. 70
    • Green, E.1    Sargent, D.2    Goldberg, R.M.3
  • 4
    • 34548242294 scopus 로고    scopus 로고
    • Reintroduction of oxaliplatin is associated with improved survival in advanced colorectal cancer
    • de Gramont A, Buyse M, Cortinas Abrahantes J, et al: Reintroduction of oxaliplatin is associated with improved survival in advanced colorectal cancer. J Clin Oncol 25:3224-3229, 2007
    • (2007) J Clin Oncol , vol.25 , pp. 3224-3229
    • de Gramont, A.1    Buyse, M.2    Cortinas Abrahantes, J.3
  • 5
    • 33644843853 scopus 로고    scopus 로고
    • OPTIMOX1: A randomized study of FOLFOX4 or FOLFOX7 with oxaliplatin in a stop-and-go fashion in advanced colorectal cancer - A GERCOR study
    • Tournigand C, Cervantes A, Figer A, et al: OPTIMOX1: A randomized study of FOLFOX4 or FOLFOX7 with oxaliplatin in a stop-and-go fashion in advanced colorectal cancer - A GERCOR study. J Clin Oncol 24:394-400, 2006
    • (2006) J Clin Oncol , vol.24 , pp. 394-400
    • Tournigand, C.1    Cervantes, A.2    Figer, A.3
  • 6
    • 34250326835 scopus 로고    scopus 로고
    • An introduction to causal modeling in clinical trials
    • Bellamy SL, Lin JY, Ten Have TR: An introduction to causal modeling in clinical trials. Clin Trials 4:58-73, 2007
    • (2007) Clin Trials , vol.4 , pp. 58-73
    • Bellamy, S.L.1    Lin, J.Y.2    Ten Have, T.R.3
  • 7
    • 0000336139 scopus 로고
    • Regression models and life tables
    • Cox DR: Regression models and life tables. J R Stat Soc B 34:187-220, 1972
    • (1972) J R Stat Soc B , vol.34 , pp. 187-220
    • Cox, D.R.1
  • 8
    • 34848827362 scopus 로고    scopus 로고
    • Association between exposure to bevacizumab (BV) beyond first progression and overall survival (OS) in patients (pts) with metastatic colorectal cancer (mCRC): Results from a large observational study (BRiTE)
    • suppl; abstr 4036, 18s
    • Grothey A, Sugrue M, Hedrick E, et al: Association between exposure to bevacizumab (BV) beyond first progression and overall survival (OS) in patients (pts) with metastatic colorectal cancer (mCRC): Results from a large observational study (BRiTE). J Clin Oncol 25:18s, 2007 (suppl; abstr 4036)
    • (2007) J Clin Oncol , vol.25
    • Grothey, A.1    Sugrue, M.2    Hedrick, E.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.